发明名称 |
AMORPHOUS ROTIGOTINE TRANSDERMAL SYSTEM |
摘要 |
The present invention refers to a transdermal device comprising a backing layer, an adhesive matrix layer comprising a supersaturated concentration of rotigotine substantially in amorphous form within the adhesive matrix, and a release liner. The present invention also refers to a method of preparing an adhesive matrix containing a supersaturated amount of rotigotine substantially in amorphous form. Further, the present invention refers to a method of stabilizing and a method of re-establishing the meta-stable amorphous-drug transdermal system during its manufacturing, storing, shipping and handling process. |
申请公布号 |
EP2349230(A2) |
申请公布日期 |
2011.08.03 |
申请号 |
EP20090749216 |
申请日期 |
2009.10.01 |
申请人 |
MYLAN TECHNOLOGIES, INC. |
发明人 |
TANG, JIANSHENG;DEVERICH, JOSEPH, M.;MILLER, KENNETH, J., II;BESTE, RUSSELL, D. |
分类号 |
A61K9/70;A61K31/381 |
主分类号 |
A61K9/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|